REVIEW PAPER
Chryseobacterium indologenes as an aetiological agent for ventilator-associated pneumonia: a case report and review of the literature
1
Students’ Scientific Society, Department of Anaesthesiology and Intensive Care, Faculty of Medical Sciences in Katowice, Medical University of Silesia, Katowice, Poland
2
Department of Anaesthesiology and Intensive Care, Faculty of Medical Sciences in Katowice, Medical University of Silesia, Katowice, Poland
Submission date: 2025-05-05
Final revision date: 2025-07-02
Acceptance date: 2025-07-13
Publication date: 2026-06-29
Corresponding author
Piotr F. Czempik
Department of Anaesthesiology and Intensive Care University Clinical Center of Medical University of Silesia Medyków 14, 40-752 Katowice, Poland
Department of Anaesthesiology and Intensive Care University Clinical Center of Medical University of Silesia Medyków 14, 40-752 Katowice, Poland
Medical Studies 2026;42(2):163-167
KEYWORDS
TOPICS
ABSTRACT
The objective of this study was to present a case of ventilator-associated pneumonia (VAP) caused by Chryseobacterium indologenes and to review the literature on this rare pathogen. A 50-year-old female patient hospitalised in the intensive care unit developed VAP. C. indologenes was identified as the sole pathogen in a culture of bronchoalveolar lavage. Targeted treatment, taking into account its natural resistance to many beta-lactam antibiotics, resulted in clinical improvement of the patient. A literature review was conducted on the aetiology and risk factors of VAP, as well as infections caused by C. indologenes, using the PubMed and Google Scholar databases. The analysis indicates that infections caused by C. indologenes are associated with high mortality, particularly among critically ill patients. This case highlights the necessity of considering C. indologenes as a potential pathogen in VAP patients. Early diagnosis and the implementation of targeted antibiotic therapy may improve prognosis.
REFERENCES (31)
1.
Papazian L, Klompas M, Luyt CE. Ventilator-associated pneumonia in adults: a narrative review. Intensive Care Med. 2020; 46(5): 888-906.
2.
Koulenti D, Tsigou E, Rello J. Nosocomial pneumonia in 27 ICUs in Europe: perspectives from the EU-VAP/CAP study. Eur J Clin Microbiol Infect Dis. 2017; 36(11): 1999-2006.
3.
Kübler A, Duszynska W, Rosenthal VD, Fleischer M, Kaiser T, Szewczyk E, Barteczko-Grajek B. Device-associated infection rates and extra length of stay in an intensive care unit of a university hospital in Wroclaw, Poland: International Nosocomial Infection Control Consortium’s (INICC) findings. J Crit Care. 2012; 27(1): e5-e10.
4.
Wałaszek M, Różańska A, Wałaszek MZ, Wójkowska-Mach J; Polish Society of Hospital Infections Team. Epidemiology of ventilator-Associated Pneumonia, microbiological diagnostics and the length of antimicrobial treatment in the Polish Intensive Care Units in the years 2013-2015. BMC Infect Dis. 2018; 18(1): 308.
5.
Pawlik J, Tomaszek L, Mazurek H, Mędrzycka-Dąbrowska W. Risk factors and protective factors against ventilator- associated pneumonia – a single-center mixed prospective and retrospective cohort study. J Pers Med. 2022; 12(4): 597.
6.
Delle Rose D, Pezzotti P, Fortunato E, Sordillo P, Gini S, Boros S, Meledandri M, Gallo MT, Prignano G, Caccese R, D’Ambrosio M, Citterio G, Rocco M, Leonardis F, Natoli S, Fontana C, Favaro M, Celeste MG, Franci T, Testore GP, Andreoni M, Sarmati L. Clinical predictors and microbiology of ventilator-associated pneumonia in the intensive care unit: a retrospective analysis in six Italian hospitals. Eur J Clin Microbiol Infect Dis. 2016; 35(9): 1531-1539.
7.
Hellyer TP, Morris AC, McAuley DF, Walsh TS, Ander- son NH, Singh S, Dark P, Roy AI, Baudouin SV, Wright SE, Perkins GD, Kefala K, Jeffels M, McMullan R, O’Kane CM, Spencer C, Laha S, Robin N, Gossain S, Gould K, Ruchaud-Sparagano MH, Scott J, Browne EM, MacFarlane JG, Wiscombe S, Widdrington JD, Dimmick I, Laurenson IF, Nauwelaers F, Simpson AJ. Diagnostic accuracy of pulmonary host inflammatory mediators in the exclusion of ventilator-acquired pneumonia. Thorax. 2015; 70(1): 41-47.
8.
Sarda C, Fazal F, Rello J. Management of ventilator-associated pneumonia (VAP) caused by resistant Gram-negative bacteria: which is the best strategy to treat? Expert Rev Respir Med. 2019; 13(8): 787-798.
9.
Zhang Y, Li D, Yang Y, Su J, Xu X, Wang M, Chen Y, Li Y. Clinical and molecular characteristics of Chryseobacterium indologenes isolates at a teaching hospital in Shanghai, China. Ann Transl Med. 2021; 9(8): 668.
10.
Bonten MJ, van Tiel FH, van der Geest S, Smeets HG, Stobberingh EE, Gaillard CA. Topical antimicrobial prophylaxis of nosocomial pneumonia in mechanically ventilated patients. Microbiological observations. Infection. 1993; 21: 137-139.
11.
Vandamme P, Bernardet JF, Segers P, Kersters K, Holmes B. New perspectives in the classification of the flavobacteria: description of Chryseobacterium gen. nov., Bergeyella gen. nov., and Empedobacter nom. rev. Int J Syst Microb. 1994; 44(4): 827-831.
12.
Mukerji R, Kakarala R, Smith SJ. Chryseobacterium indologenes: an emerging pathogen causing nosocomial infections. Int J Case Rep Images. 2016; 7(9): 570-573.
13.
Chang J, Kim S, Kwak YG, Um TH, Cho CR, Song JE. Clinical and microbiological characteristics of Chryseobacterium indologenes bacteremia: a 20-year experience in a single university hospital. Infect Chemother. 2023; 55(3): 322-327.
14.
Ojdana D, Gińdzieńska-Sieśkiewicz E, Sacha P, Wieczo- rek P, Krawczyk M, Kita K, Michalska A, Sierakowski S, Tryniszewska E. Chryseobacterium indologenes carrying blaIND-1 isolated from blood obtained from a patient with adenocarcinoma: a case report and minireview of the literature. Clin Microbiol Rev. 2015; 26(3): 119-124.
15.
Chung-Shien Lu P, Cheng-Ho CJ. Flavobacterium indologenes keratitis. Ophthalmologica. 1997; 211(2): 98-100.
16.
Ramos-Esteban JC, Bamba S, Jeng BH. Treatment of multidrug-resistant Flavobacterium indologenes keratitis with trimethoprim-sulfamethoxazole. Cornea. 2008; 27(9): 1074- 1076.
17.
Lee IJ, Mauger T. Chryseobacterium indologenes keratitis: successful treatment of multidrug-resistant strain. Case Rep Ophthalmol Med. 2021; 2021: 5527775.
18.
Calderón G, García E, Rojas P, García E, Rosso M, Losada A. Chryseobacterium indologenes infection in a newborn: a case report. J Med Case Rep. 2011; 5: 10.
19.
Atıcı S, Ünkar ZA, Erdem K, Kadayifci EK, Karaaslan A, Memişoğlu AÇ, Soysal A, Toprak NÜ, Söyletir G, Özek E, Bakır M. Ventilator-associated pneumonia caused by Chryseobacterium indologenes: a rare infant case and review of the literature. Springerplus. 2016; 5(1): 1741.
20.
Bhagawati G, Bhardwaj A, Sajikumar R, Singh SP, Prajapati S. Bacteremia by Chryseobacterium indologenes in a patient with lung cancer: a clinical and microbiological investigation. Indian J Crit Care Med. 2019; 23: 157-159.
21.
Khajuria A, Praharaj AK, Kumar M, Grover N. A case of septicemia due to Chyresobacterium indologenes producing blaNDM-1. Avicenna J Med. 2014; 4(3): 71-73.
22.
Chou DW, Wu SL, Lee CT, Tai FT, Yu WL. Clinical characteristics, antimicrobial susceptibilities, and outcomes of patients with Chryseobacterium indologenes bacteremia in an intensive care unit. Jpn J Infect Dis 2011; 64(6): 520-524.
23.
Corbella M, Brandolini M, Cambieri P, Decembrino N, Pagani M, Bottazzi A, Muzzi A, Zecca M, Mariani B, Marone P. A catheter-related bloodstream infection caused by Chryseobacterium indologenes successfully treated with antibiotic-lock rescue therapy. New Microbiol. 2017; 40(3): 223-225.
24.
Chen FL, Wang GC, Teng SO, Ou TY, Yu FL, Lee WS. Clinical and epidemiological features of Chryseobacterium indologenes infections: analysis of 215 cases. J Microbiol Immunol Infect. 2013; 46(6): 425-432.
25.
Cantero M, Parra LM, Muñez E, Iranzo R, Sánchez-Romero MI, Oteo J, Asensio A. A cluster of Chryseobacterium indologenes cases related to drainage water in intensive care units. Infect Control Hosp Epidemiol. 2018; 39(8): 997-999.
26.
Ozcan N, Dal T, Tekin A, Kelekci S, Can S, Ezin O, Kandemir I, Gul K. Is Chryseobacterium indologenes a shunt-lover bacterium? A case report and review of the literature. Infez Med. 2013; 21(4): 312-316.
27.
Kirby JT, Sader HS, Walsh TR, Jones RN. Antimicrobial susceptibility and epidemiology of a worldwide collection of Chryseobacterium spp: report from the SENTRY Antimicrobial Surveillance Program (1997–2001). J Clin Microbiol. 2004; 42: 445-448.
28.
Hsueh PR, Teng LJ, Yang PC, Ho SW, Hsieh WC, Luh KT. Increasing incidence of nosocomial Chryseobacterium indologenes infections in Taiwan. Eur J Clin Microbiol Infect Dis. 1997; 16: 568-574.
29.
Arif N, Khullar S, Kumar R, Choudhary SK, Kapil A, Dhawan B. Pleural effusion due to Chryseobacterium indologenes: case report and review of literature. J Lab Physicians. 2019; 11(3): 284-286.
30.
Machchhar RR, Yang JS, Figueroa M, Ghodasara K, Ha- san B. A curious case of Chryseobacterium indologenes culture in a young adult kidney transplant patient. Cureus. 2023; 15(1): e33395.
31.
Chang YC, Lo HH, Hsieh HY, Chang SM. Identification, epidemiological relatedness, and biofilm formation of clinical Chryseobacterium indologenes isolates from central Taiwan. J Microbiol Immunol Infect. 2015; 48: 559-564.
Share
RELATED ARTICLE
| eISSN: | 2300-6722 |
| ISSN: | 1899-1874 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
